L COREY, KH FIFE, JK BENEDETTI, CA … - Annals of Internal Medicine, 1983 - Am Coll Physicians Thirty-one patients with first episodes of genital herpes were randomized in a
double-blind fashion to intravenous treatment with saline placebo or acyclovir,
5 mg/kg body weight at 8-hour intervals, for 5 days. The median duration of ... Cited by 147 - Related articles - All 2 versions
GJ Mertz, CW Critchlow, J Benedetti, RC … - JAMA: The Journal of the American Medical …, 1984 - jama.ama-assn.org.p.angrylapdog.com One hundred nineteen patients with primary and 31 patients with nonprimary
first-episode genital herpes were treated for ten days with 200 mg of acyclovir
capsules or placebo capsules orally five times daily. Among acyclovir ... Cited by 138 - Related articles - Cached - All 4 versions
A Mindel, MW Adler, S Sutherland, AP Fiddian - The Lancet, 1982 - Elsevier 30 patients with a severe first attack of genital herpes were treated with
intravenous acyclovir in a randomised, double-blind, placebo-controlled trial.
The medians for healing time, duration of vesicles, new lesion formation, ... Cited by 109 - Related articles - All 3 versions
YJ Bryson, M Dillon, M Lovett, G Acuna, S … - New England Journal of Medicine, 1983 - content.nejm.org We performed a double-blind placebo-controlled trial of oral acyclovir in the
treatment of first episodes of genital herpes simplex virus infections in 48
young adults (31 women and 17 men). Subjects were randomized to receive ... Cited by 231 - Related articles - All 2 versions
AE Nilsen, T Aasen, AM Halsos, BR Kinge, EA … - The Lancet, 1982 - Elsevier A double-blind, randomised trial of acyclovir versus placebo was conducted in 31
patients with initial and 85 patients with recurrent genital herpes. 17 patients
with initial and 42 with recurrent disease were treated with 200 mg ... Cited by 159 - Related articles - All 5 versions
L Corey, AJ NAHMIAS, ME Guinan, JK … - Obstetrical & Gynecological Survey, 1982 - journals.lww.com Infections and the Immune Response 679 ods which are sufficiently diverse to be
ac- ceptable to all. Only in this way can we prevent abortion from being used as
a contraceptive method. It is especially important to devise for women over ... Cited by 186 - Related articles - All 3 versions
RC Reichman, GJ Badger, GJ Mertz, L Corey, … - Jama, 1984 - Am Med Assoc Two hundred fifty patients were entered into a multicenter trial to evaluate the
efficacy and toxicity of orally administered acyclovir for treatment of
recurrent genital herpes. The study consisted of part A, in which patients ... Cited by 219 - Related articles - All 4 versions
JM DOUGLAS, C CRITCHLOW, J BENEDETTI … - Obstetrical & Gynecological Survey, 1984 - journals.lww.com 652 Obstetrical and Gynecological Survey of the newborn were more severely
sensitized than infants with blood group A. The authors conclude that the
frequency dis- tributions suggest a role for ABO incompatibili- ties which ... Cited by 250 - Related articles - All 4 versions
SE Straus, HE Takiff, M Seidlin, S Bachrach, … - New England Journal of Medicine, 1984 - content.nejm.org We studied 35 otherwise healthy adults with frequently recurring genital herpes
(greater than or equal to 1 episode per month), in a double-blind trial
comparing oral acyclovir with placebo capsules for suppression of recurrent ... Cited by 220 - Related articles - All 3 versions
SL Sacks, FY Aoki, F Diaz-Mitoma, J Sellors, … - Jama, 1996 - Am Med Assoc OBJECTIVE--To compare the efficacy and safety of episodic patient-initiated oral
famciclovir with placebo in recurrent genital herpes. DESIGN--Randomized,
double-blind, frequent-observation, dose-ranging study comparing ... Cited by 129 - Related articles - BL Direct - All 3 versions
